177Lu-JH04
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 177Lu-JH04, covering 2024-10-10 to 2024-10-10. Get the full timeline:
Most recent: Clinical Trial Update: 177Lu-JH04 in Patients with FAP-Positive Tumors [EARLY_Phase 1]